Interaction between interleukin-1 and ciliary neurotrophic factor in the regulation of neuroblastoma cell functions

European Cytokine Network

Volumn 8, Issue 4, 1997, Pages 367-374

  Bossù, Paola ^a   Ruggiero, Paolo ^a   Macchia, Giovanni ^a   Maurizi, Giovanni ^b   Bizzarri, Cinzia ^b   Neumann, Detlef ^c   Tagliabue, Aldo ^a   Boraschi, Diana ^a  

^a Chemistry Section   (Italy)

^b Consorzio Biolaq ^*  (Italy)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Calcium fluxes; CNTF; IL 1 receptors; Inflammatory cytokines; Interleukin 1

Indexed keywords

CALCIUM ION; CARBACHOL; CHOLINERGIC RECEPTOR; CILIARY NEUROTROPHIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ARTICLE; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CILIARY NEUROTROPHIC FACTOR; DOWN-REGULATION; HUMANS; INFLAMMATION; INTERLEUKIN-1; NERVE TISSUE PROTEINS; NEUROBLASTOMA; NEURONS; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-1; TRANSCRIPTION, GENETIC;

EID: 0031463462     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Besedovsky H, del Roy A, Sorkin E, Dinarello C A. 1986. Immunoregulatory feed back between interleukin-1 and glucocorticoid hormones. Science 233: 652.
2. Berkenbosch F, van Oers J, del Rev A, Tilders F, Besedovsky H. 1987. Corticotropin-releasing factor-producing neurons in the rat activated by interletikin-1. Science 238: 524.
3. Dinarello C A. 1996. Biologic basis tor interleukin-1 in disease. (Review) Blood 87: 2095.
4. Rothwell N J. 1991. Functions and mechanisms of interleukin-1 in the brain. (Review) Trends Pharmacol. Sci. 12: 430.
5. Rothwell N J, Luheshi G. 1994. Pharmacology of interleukin-1 actions in the brain. (Review) Adv. Pharmamcol. 25: 1.
6. Hopkins S J, Rothwell N J. 1995. Cytokincs and the nervous system I: expression and recognition. (Review) Trends Neurosci. 18: 83.
7. Rothwell N J, Hopkins S J. 1995. Cytokines and the nervous system II: Actions and mechanisms of action. (Review) Trends Neurosci. 18: 130.
8. Vandenabeele P, Fiers W. 1991. Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6-mediated "acute phase response" in the brain? (Review) Immunol. Today 12: 217.
9. Rothwell N J, Relton J K. 1993. Involvement of cytokines in acute neurodegeneration in the CNS. (Review) Neurosci. Biobehav. Rev. 17: 217.
10. Waage A, Halstensen A, Shalahy R, Brandtzaeg P, Kierulf P, Espevik T. 1989. Local production of tumor necrosis factor-α, interleukin-1, and interleukin-6 in meningococcal meningitis. Relation to the inflammatory response. J. Exp. Med. 170: 1859.
11. Farrar WL, Kilian P L, Ruff M R, Hill J M, Pert C B, 1987. Visualization and characterization of interleukin-1 receptors in brain. J. Immunol. 139: 459.
12. Katsuura G, Gottschall P E, Arimura A. 1988. Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem. Biophys. Res. Commun. 156: 61.
13. Bristulf J, Simoncsits A, Bartfai T. 1991. Characterization of a neuronal interleukin-1 receptor and the corresponding mRNA in the mouse anterior pituitary cell line AtT-20. Neurosci. Lett. 128: 173.
14. Ban E, Haour F, Lenstra R. 1992. Brain interleukin-1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 4: 48.
15. Kent S, Bluthé R M, Dantzer R, Hardwick A J, Kelley K W, Rothwell N J, Vannice J L. 1992. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin-1. Proc. Natl. Acad. Sci. USA 89: 9117.
16. Ban E, Marquette C, Sarrieau A, Fitzpatrick F, Fillion G, Milon G, Rostene W, Haour F. 1993. Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology 58: 581.
17. Luheshi G, Hopkins S J, Lefeuvre R A, Dascombe M J, Ghiara P, Rothwell N J. 1993. Importance of brain IL-I type II receptors in fever and thermogenesis in the rat. Am. J. Physiol. 265: E585.
18. Stalder A K, Campbell I L. 1994. Simultaneous analysis of multiple cytokine receptor mRNAs by RNAse protection assay in LPS-induced endotoxemia. Lymphokine Cytokine Res. 13: 107.
19. Yabuuchi K, Minami M, Katsumata S, Satoh M. 1994. Localization of type I interleukin-1 receptor mRMA in the rat brain. Brain Res. Mol. Brain Res. 27: 27.
20. Parnet P, Amindari S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer J A, Dantzer R, Kelley K W. 1994. Expression of type I and type II interleukin-1 receptors in the mouse brain. Brain Res. Mol. Brain Res. 27: 63.
21. Takao T, Nakata H, Tojo C, Kurokawa H, Nishioka T, Hashimoto K, De Souza E B. 1994. Regulation of interleukin-1 receptors and hypothalamic-pituitary-adrenal axis by lipopolysaccharide treatment in the mouse. Brain Res. 649: 265.
22. Mirtella A, Tringali G, Guerriero G, Ghiara P, Parente L, Preziosi P, Navarra P. 1995. The interleukin-1β-induced prostaglandin E, release from rat hypothalamus is mediated by type 1 and type II interleukin-1 receptors. J. Neuroimmunol. 61: 171.
23. Lindholm D, Heumann R, Meyer M, Thoenen H. 1987. lnterleukin-1 regulates synthesis of nerve growth factor in nonneuronal cells of rat sciatic nerve. Nature 330: 658.
24. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H, Näher-Noé M, Thoenen H. 1990. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2: 69.
25. Hughes S M, Lillien L E, Raff M C, Rohrer H, Sendtner M. 1988. Ciliary neurotrophic factor induces type-2 astrocyte differentiation in culture. Nature 335: 70.
26. Ip N Y, Li Y P, van de Stadt I, Panayotatos N, Alderson R F, Lindsay R M. 1991. Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J. Neurosci. 11: 3124.
27. Oppenheim R W, Prevette D, Yin Q W, Collins F, Mac Donald J. 1991. Control of embryonic motoneuron survival in vivo by ciliary neurotrophic factor. Science 251: 1616.
28. Louis J C, Magal E, Takayama S, Varon S. 1993. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 259: 689.
29. Shapiro L, Zhang X X, Rupp R P, Wolff S M, Dinarello C A. 1993. Ciliary neurotrophic factor is an endogenous pyrogen. Proc. Natl. Acad. Sci. USA 90: 8614.
30. Fantuzzi G, Benigni F, Sironi M, Conni M, Carelli M, Cantoni L, Shapiro L, Dinarello C A, Sipe J D, Ghezzi P. 1995. Ciliary neurotrophic factor (CNTF) induces serum amyloid A, hypoglycaemia and anorexia, and potentiates IL-1-induced corticosterone and IL-6 production in mice. Cytokine 7: 150.
31. Henderson J T, Seniuk N A, Richardson P M, Gauldie J, Roder J C. 1994. Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J. Clin. Invest. 93: 2632.
32. Benigni F, Villa P, Demitri M T, Sacco S. Sipe J D, Lagunowich L, Panayotatos N, Ghezzi P. 1995. Ciliary neurotrophic factor inhibits brain and peripheral tumor necrosis factor production and, when coadministered with its soluble receptor, protects mice from lipopolysaccharide toxicity. Mol. Med. 1: 568.
33. Benigni F, Fantuzzi G, Sacco S, Sironi M. Pozzi P, Dinarello C A, Sipe J D, Poli V, Cappelletti M, Paonessa G, Pennica D. Panayotatos N, Ghezzi P. 1996. Six different cytokines that shares gp130 as a receptor subunit induce serum amyloid A and potentiate the induction of IL-6 and the activation of the hypothalamus-pituitary-adrenal axis by interelukin-1. Blood 87: 1851.
34. 2 in vitro. Exp. Cell Res. 215: 51.
35. Bossù P, Visconti U, Ruggiero P, Macchia G, Muda M, Bertini R, Bizzarri C, Colagrande A, Sabbatini V, Maurizi G, Del Grosso E, Tagliabue A, Boraschi D. 1995. Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1. Am. J. Pathol. 147: 1852.
36. Boraschi D, Bossù P, Ruggiero P, Tagliabue A, Bertini R, Macchia G, Gasbarro C, Pellegrini L, Melillo G, Ulisse E, Visconti U, Bizzarri C, Del Grosso E, Mackay A R, Frascotti G, Frigerio F, Grifantini R, Grandi G. 1995. Mapping of receptor binding sites on IL-1β by reconstruction of IL-1ra-like domains. J. Immunol. 155: 4719.
37. Stoppacciaro A, Bossù P, Ghiara P, Ruco L P, Censini S, Scapigliati G, Nuti S, Tagliabue A, Baroni C D, Boraschi D. 1991. Binding of IL-1β to IL-IR type II at single cell level. J. Immunol. 147: 1561.
38. Munson P J, Rodbard D. 1980. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220.
39. Sambrook J, Fritsch E F, Maniatis T. 1989. Molecular Cloning: a Laboratory Manual. Second Edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY. 1626.
40. 2+ increase in human adherent monocytes. Blood 86: 2388.
41. Scapigliati G, Ghiara P, Bartalini M, Tagliabue A, Boraschi D. 1989. Differential binding of IL-1α and IL-1β to receptors on B and T cells. FEBS Lett. 243: 394.
42. Colotta F, Dower S K, Sims J E, Mantovani A. 1994. The type 11 "decoy" receptor: a novel regulatory pathway for interleukin-1. (Review) Immunol. Today 15: 562.
43. Greenfeder S A, Nunes P, Kwee L, Labow M, Chizzonite R A, JuG. 1995. Molecular cloning and characterization of a second suhunit of the interleukin-1 receptor complex. J. Biol. Chem. 270: 13757.
44. Chung I Y, Benveniste E N. 1990. Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-Iβ. J. Immunol. 144: 2999.
45. Hartung H P, Schäfer B, Heininger K, Toyka K V. 1989. Recombinant interleukin-1β stimulates eicosanoid production in rat primary culture astrocytes. Brrain Res. 489: 113.
46. 1 in human neuroblastoma (SH-SY5Y) cells expressing recombinant rat angiotensin I A receptors by angiotensin II and carbachol. J. Pharmacol. Exp. Ther. 281: 1257.
47. 2+/calmodulin-dependent protein kinase inhibitor 1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-trosyl|-4-phenyl-piperazine (KN-62). Biochem. Pharmacol. 53: 1107.
48. Liu P S, Shaw Y H. 1997. Arginine-modulated receptor-activated calcium influx via a NO/cyclic GMP pathway in human SK-N-SH neuroblastoma cells. J. Neurochem. 68: 376.